IDEXX LABORATORIES INC /DE Property, Plant and Equipment
IDEXX LABORATORIES INC /DE (IDXX) had Property, Plant and Equipment of $733.24 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-04
- 2026-06-30: Property, Plant and Equipment, Net $733.24M.
- 2026-03-31: Property, Plant and Equipment, Net $740.38M.
- 2025-12-31: Property, Plant and Equipment, Net $747.38M.
- 2025-09-30: Property, Plant and Equipment, Net $739.44M.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-06-30 | $733.24M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $740.38M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $747.38M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $739.44M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $739.68M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $717.62M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $713.12M 10-K · filed 2026-02-20 |
| 2024-09-30 | $717.75M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $708.18M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $708.73M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $702.18M 10-K · filed 2025-02-21 |
| 2023-09-30 | $687.10M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $683.27M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $665.44M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $649.47M 10-K · filed 2024-02-22 |
| 2022-09-30 | $612.40M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $594.22M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $593.46M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $587.67M 10-K · filed 2023-02-16 |
| 2021-09-30 | $573.38M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $550.25M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $543.96M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $555.17M 10-K · filed 2022-02-16 |
| 2020-09-30 | $547.62M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $550.89M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $546.16M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $533.85M 10-K · filed 2021-02-12 |
| 2019-09-30 | $496.58M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $469.98M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $449.10M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $437.27M 10-K · filed 2020-02-14 |
| 2018-09-30 | $409.98M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $394.02M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $384.25M 10-Q · filed 2018-05-04 |
| 2018-01-01 | $379.10M 10-K · filed 2019-02-15 |
| 2017-12-31 | $379.10M 10-K · filed 2019-02-15 |
| 2017-09-30 | $367.51M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $364.78M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $361.23M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $357.42M 10-K · filed 2018-02-16 |
| 2016-09-30 | $349.66M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $347.16M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $343.01M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $333.03M 10-K · filed 2017-02-17 |
| 2015-09-30 | $320.34M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $326.04M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $309.83M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $303.59M 10-K · filed 2016-02-17 |
| 2014-09-30 | $291.70M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $286.71M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $282.23M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $281.21M 10-K · filed 2015-02-17 |
| 2013-09-30 | $274.16M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $266.49M 10-Q · filed 2013-07-23 |
| 2013-03-31 | $253.74M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $245.18M 10-K · filed 2014-02-18 |
| 2012-09-30 | $231.64M 10-Q · filed 2012-10-19 |
| 2012-06-30 | $220.58M 10-Q · filed 2012-07-20 |
| 2012-03-31 | $216.93M 10-Q · filed 2012-04-20 |
| 2011-12-31 | $216.78M 10-K · filed 2013-02-19 |
| 2011-09-30 | $213.87M 10-Q · filed 2011-10-21 |
| 2011-06-30 | $210.16M 10-Q · filed 2011-07-22 |
| 2011-03-31 | $202.75M 10-Q · filed 2011-04-21 |
| 2010-12-31 | $201.72M 10-K · filed 2012-02-17 |
| 2010-09-30 | $200.61M 10-Q · filed 2010-10-22 |
| 2010-06-30 | $196.71M 10-Q · filed 2010-07-23 |
| 2009-12-31 | $199.95M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |